Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ivannie Ortiz-Rivera"'
Autor:
Nadine Nelson, Karoly Szekeres, Cristina Iclozan, Ivannie Ortiz Rivera, Andrew McGill, Gbemisola Johnson, Onyekachi Nwogu, Tomar Ghansah
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0170197 (2017)
Pancreatic cancer (PC) evades immune destruction by favoring the development of regulatory T cells (Tregs) that inhibit effector T cells. The transcription factor Ikaros is critical for lymphocyte development, especially T cells. We have previously s
Externí odkaz:
https://doaj.org/article/f422de9d25b14847933d98db26bac17a
Autor:
Alvaro de Mingo Pulido, Charles Adelmann, Brittney Sell, Karol Prieto, Kimberly Nguyen, Cynthia Dixey, Ivannie Ortiz-Rivera, Marco Napoli, Elsa Flores, Jason Fleming, Karen Mann, Christin Burd, Kenneth Y. Tsai
Publikováno v:
Molecular Cancer Research. 21:A010-A010
Overall, some 30% of human cancers are driven by mutant RAS proteins, which have proven relatively difficult to target. While immunotherapy is effective for NRAS-mutant melanoma, no options exist for resistant disease, and mutant KRAS-driven lung and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59d56b2a7e1c4172bdd99f34aa107b28
https://doi.org/10.1158/1557-3125.ras23-a010
https://doi.org/10.1158/1557-3125.ras23-a010
Autor:
Vida Chitsazzadeh, Tran N. Nguyen, Alvaro de Mingo Pulido, Bruna B. Bittencourt, Lili Du, Charles H. Adelmann, Ivannie Ortiz Rivera, Kimberly A. Nguyen, Leah D. Guerra, Andrew Davis, Marco Napoli, Wencai Ma, Richard Eric Davis, Kimal Rajapakshe, Cristian Coarfa, Elsa R. Flores, Kenneth Y. Tsai
Publikováno v:
Journal of Investigative Dermatology. 142:1956-1965.e2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4107cf1b6babfa39f3069d45e3d19232
https://doi.org/10.1016/j.jid.2021.09.040
https://doi.org/10.1016/j.jid.2021.09.040
Autor:
Margaret L. Hibbs, DeVon DeLoach, Kun Jiang, Gerald Krystal, Kazim Husain, Ciara Alvarez, Krystal Villalobos-Ayala, Ivannie Ortiz Rivera, Tomar Ghansah
Publikováno v:
Cancers
Volume 12
Issue 12
Cancers, Vol 12, Iss 3631, p 3631 (2020)
Volume 12
Issue 12
Cancers, Vol 12, Iss 3631, p 3631 (2020)
Pancreatic cancer (PC) has an extremely poor prognosis due to the expansion of immunosuppressive myeloid-derived suppressor cells (MDSC) and tumor-associated macrophages (TAM) in the inflammatory tumor microenvironment (TME), which halts the recruitm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e3b602f9dbc030b15812c0d57ca3b0a
Autor:
Sandra S. Ojeda, Kevin N. Dalby, Tran N. Nguyen, Tinghu Zhang, Ivannie Ortiz-Rivera, Tamer S. Kaoud, K Nguyen, Kenneth Y. Tsai, Anna Anderson, Lili Du, Nathanael S. Gray
Publikováno v:
ACS Chem Biol
Overexpression and activation of c-Jun N-terminal kinases (JNKs) have been observed in multiple cancer cell lines and tumor samples. Various JNK isoforms have been reported to promote lung and liver cancer, as well as keratinocyte transformation, sug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cad5ba0f4d649c5ba235c6fa5c20403
https://europepmc.org/articles/PMC7181303/
https://europepmc.org/articles/PMC7181303/
Autor:
Rebecca S Hesterberg, Elsa R. Flores, B. Sell, K Nguyen, Omar Chavez Chiang, Brian L. Murphy, L. Tordesillas, Ivannie Ortiz-Rivera, Kenneth Y. Tsai, Pearlie K. Burnette
Publikováno v:
Cancer Research. 79:1227-1227
Cutaneous squamous cell carcinoma (cuSCC) accounts for 15-20% of skin cancers. Treatment of cuSCC with pramlintide, a synthetic analog of the hormone amylin, is currently under investigation in mouse models and human clinical trials. In cancer cells,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::79e858e54cdbaca13b935baab96b2408
https://doi.org/10.1158/1538-7445.am2019-1227
https://doi.org/10.1158/1538-7445.am2019-1227
Autor:
Nadine Nelson, Ivannie Ortiz Rivera, Tomar Ghansah, Gbemisola Johnson, Onyekachi Nwogu, Andrew R. McGill, Cristina Iclozan, Karoly Szekeres
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 2, p e0170197 (2017)
PLoS ONE, Vol 12, Iss 2, p e0170197 (2017)
Pancreatic cancer (PC) evades immune destruction by favoring the development of regulatory T cells (Tregs) that inhibit effector T cells. The transcription factor Ikaros is critical for lymphocyte development, especially T cells. We have previously s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2dccf48ea10b4c8b1894c4200375d5c
https://pubmed.ncbi.nlm.nih.gov/28152014
https://pubmed.ncbi.nlm.nih.gov/28152014
Publikováno v:
The Journal of Immunology. 196:72.11-72.11
Pancreatic Cancer (PC) is one of the most aggressive and deadliest types of cancer, and it is projected to be the second leading cause of cancer-related deaths in the U.S. by the year 2030. PC evades immune surveillance by disrupting the immune homeo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da03c1a684efc0cc586704faa749678f
https://doi.org/10.4049/jimmunol.196.supp.72.11
https://doi.org/10.4049/jimmunol.196.supp.72.11
Publikováno v:
The Journal of Immunology. 196:211.9-211.9
Pancreatic cancer (PC) is an aggressive disease with minimally effective therapies due to immunosuppression. Src Homology Inositol Phosphatase (SHIP-1) expression is essential in regulating myeloid derived suppressor cell (MDSC) and T regulatory cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9b28467ead4c62fbaa46a721b207a39
https://doi.org/10.4049/jimmunol.196.supp.211.9
https://doi.org/10.4049/jimmunol.196.supp.211.9